All Stories

  1. Epstein-Barr Virus infection patterns in immune, glial, and nerve cells in multiple sclerosis
  2. Hunger guides immunity to friend versus foe
  3. Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy
  4. Molecular signature of Epstein-Barr virus infection in MS brain lesions
  5. Towards ‘off-the-shelf’ genetically modified T cells: prolonging functional engraftment in mice by CD8 veto T cells
  6. Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide
  7. The evolution of T-cell depletion in haploidentical stem-cell transplantation
  8. The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT
  9. Exercising ‘Veto’ Power to Make Haploidentical Hematopoietic Stem Cell Transplantation a Safe Modality for Induction of Immune Tolerance
  10. Megadose stem cell administration as a route to mixed chimerism
  11. A new approach for eradication of residual lymphoma cells by host nonreactive anti–third-party central memory CD8 T cells
  12. Murine anti–third-party central-memory CD8+ T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells
  13. Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: The role of ex-vivo generated donor CD8+ T cells with central memory phenotype